Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2016

Open Access 01-12-2016 | Research article

Wenyang Huazhuo Tongluo formula, a Chinese herbal decoction, improves skin fibrosis by promoting apoptosis and inhibiting proliferation through down-regulation of survivin and cyclin D1 in systemic sclerosis

Authors: Li Han, Hua Bian, Jingfeng Ouyang, Yuefeng Bi, Lei Yang, Songshan Ye

Published in: BMC Complementary Medicine and Therapies | Issue 1/2016

Login to get access

Abstract

Background

Fibrosis is a major contributor to systemic sclerosis (SSc)-related morbidity, and rapid, progressive skin involvement predicts later mortality. Western medicine therapies for SSc cannot produce satisfactory effects currently, while Traditional Chinese Medicine (TCM), such as the Wenyang Huazhuo Tongluo (WYHZTL) formula, a Chinese herbal decoction, has shown amazing anti-fibrosis efficacy on SSc in clinical applications. This study is aiming to investigate the anti-fibrotic mechanism of WYHZTL formula for the treatment of SSc.

Methods

Fibroblasts from primary culture of skin lesions of SSc patients were exposed to rat medicated sera containing WYHZTL or XAV939, a small-molecule inhibitor of both tankyrase 1/2 and Wnt/β-catenin pathway. Cell counting kit-8 assay and Annexin V FITC/PI apoptosis kit were used to analyze cell proliferation and apoptosis in fibroblasts, respectively. Reverse transcription-polymerase chain reaction (RT-PCR) and western blotting were used to detect the mRNA and protein levels of cyclin D1 and survivin.

Results

After 28, 48 and 72 h of incubation, the proliferative ability of the fibroblasts cells was obviously reduced by the sera containing WYHZTL compared with that in the control group; the percentage of apoptotic cell population in the sera containing WYHZTL treated fibroblasts cells was significantly higher than that in those treated with the control sera, and was about similar to that in those treated with XAV939. The sera containing WYHZTL could down-regulate both mRNA and protein levels of cyclin D1 and survivin, compared with the control group.

Conclusions

The present study demonstrates the antiproliferative and pro-apoptotic actions of WYHZTL formula against fibroblasts and the effect may be related to the down-regulation of mRNA and protein levels of cyclin D1 and survivin in SSc.
Literature
2.
go back to reference Bagnato GL, Roberts WN, Fiorenza A, et al. Skin fibrosis correlates with circulating thyrotropin levels in systemic sclerosis: translational association with Hashimoto’s thyroiditis. Endocrine. 2015; doi:10.1007/s12020-015-0600-3. Bagnato GL, Roberts WN, Fiorenza A, et al. Skin fibrosis correlates with circulating thyrotropin levels in systemic sclerosis: translational association with Hashimoto’s thyroiditis. Endocrine. 2015; doi:10.​1007/​s12020-015-0600-3.
3.
go back to reference Antic M, Distler JH, Distler O. Treating skin and lung fibrosis in systemic sclerosis: a future filled with promise. Curr Opin Pharmacol. 2013;13(3):455–62.CrossRefPubMed Antic M, Distler JH, Distler O. Treating skin and lung fibrosis in systemic sclerosis: a future filled with promise. Curr Opin Pharmacol. 2013;13(3):455–62.CrossRefPubMed
4.
go back to reference Jordan S, Chung J, Distler O. Preclinical and translational research to discover potentially effective antifibrotic therapies in systemic sclerosis. Curr Opin Rheumatol. 2013;25(6):679–85.CrossRefPubMed Jordan S, Chung J, Distler O. Preclinical and translational research to discover potentially effective antifibrotic therapies in systemic sclerosis. Curr Opin Rheumatol. 2013;25(6):679–85.CrossRefPubMed
5.
go back to reference Kou S, Zheng Q, Wang Y, et al. Zuo-Gui and You-Gui pills, two traditional Chinese herbal formulas, downregulated the expression of NogoA, NgR, and RhoA in rats with experimental autoimmune encephalomyelitis. J Ethnopharmacol. 2014;158:102–12.CrossRefPubMed Kou S, Zheng Q, Wang Y, et al. Zuo-Gui and You-Gui pills, two traditional Chinese herbal formulas, downregulated the expression of NogoA, NgR, and RhoA in rats with experimental autoimmune encephalomyelitis. J Ethnopharmacol. 2014;158:102–12.CrossRefPubMed
6.
go back to reference Yan XN, Feng J, Li WB, Cui R, Shi BJ. Effects of Wenyang Chubi Decoction on connective tissue growth factor and collagen-I in a mouse model of scleroderma. Zhong Xi Yi Jie He Xue Bao. 2007;5(5):526–30.CrossRefPubMed Yan XN, Feng J, Li WB, Cui R, Shi BJ. Effects of Wenyang Chubi Decoction on connective tissue growth factor and collagen-I in a mouse model of scleroderma. Zhong Xi Yi Jie He Xue Bao. 2007;5(5):526–30.CrossRefPubMed
7.
go back to reference Wu T, Chu H, Tu W, et al. Dissection of the mechanism of traditional Chinese medical prescription-Yiqihuoxue formula as an effective anti-fibrotic treatment for systemic sclerosis. BMC Complement Altern Med. 2014;14:224.PubMedCentralCrossRefPubMed Wu T, Chu H, Tu W, et al. Dissection of the mechanism of traditional Chinese medical prescription-Yiqihuoxue formula as an effective anti-fibrotic treatment for systemic sclerosis. BMC Complement Altern Med. 2014;14:224.PubMedCentralCrossRefPubMed
8.
go back to reference Hua B, Min Y, Gao Z, et al. Effect of Wenyang Huazhuo Tongluo Recipe on Peripheral Blood Th17/Treg Cell Balance In Systemic Sclerosis Patient. Zhongguo Zhongxiyi Jiehe Zazhi. 2015;35(08):975–9. Hua B, Min Y, Gao Z, et al. Effect of Wenyang Huazhuo Tongluo Recipe on Peripheral Blood Th17/Treg Cell Balance In Systemic Sclerosis Patient. Zhongguo Zhongxiyi Jiehe Zazhi. 2015;35(08):975–9.
9.
go back to reference Bian H, Lv Q, Han L, et al. Impact of Wenyang Huazhuo Tongluo Formula on TGF-β1 /Smad Signal Pathway of Systemic Sclerosis Mouse Model. J Tradit Chin Med. 2015;56(04):327–31. Bian H, Lv Q, Han L, et al. Impact of Wenyang Huazhuo Tongluo Formula on TGF-β1 /Smad Signal Pathway of Systemic Sclerosis Mouse Model. J Tradit Chin Med. 2015;56(04):327–31.
10.
go back to reference Bian H, Qin LV, Huang X, et al. The effects of Wenyang Huazhuo Tongluo Recipe On TGF-β1/Smad Signaling pathway of fibroblasts in Systemic sclerosis patients. Zhongguo Zhongxiyi Jiehe Zazhi. 2015;35(9):1054–8.PubMed Bian H, Qin LV, Huang X, et al. The effects of Wenyang Huazhuo Tongluo Recipe On TGF-β1/Smad Signaling pathway of fibroblasts in Systemic sclerosis patients. Zhongguo Zhongxiyi Jiehe Zazhi. 2015;35(9):1054–8.PubMed
11.
go back to reference Bian H, Fan YS, Lou LH, Mao BY, Shi JY. Effect of Wenyang Huazhuo Tongluo recipe contained serum on proliferation and cell cycle of systemic sclerosis skin fibroblasts. Zhong Yao Cai. 2009;32(6):936–9.PubMed Bian H, Fan YS, Lou LH, Mao BY, Shi JY. Effect of Wenyang Huazhuo Tongluo recipe contained serum on proliferation and cell cycle of systemic sclerosis skin fibroblasts. Zhong Yao Cai. 2009;32(6):936–9.PubMed
12.
go back to reference Blagosklonny MV, Pardee AB. The restriction point of the cell cycle. Cell Cycle. 2002;1(2):103–10.CrossRefPubMed Blagosklonny MV, Pardee AB. The restriction point of the cell cycle. Cell Cycle. 2002;1(2):103–10.CrossRefPubMed
15.
go back to reference Cheung CH, Chen HH, Kuo CC, et al. Survivin counteracts the therapeutic effect of microtubule de-stabilizers by stabilizing tubulin polymers. Mol Cancer. 2009;8:43.PubMedCentralCrossRefPubMed Cheung CH, Chen HH, Kuo CC, et al. Survivin counteracts the therapeutic effect of microtubule de-stabilizers by stabilizing tubulin polymers. Mol Cancer. 2009;8:43.PubMedCentralCrossRefPubMed
16.
go back to reference Xu H, Wu Q, Peng C, Zhou L. Study on the antiviral activity of San Huang Yi Gan Capsule against hepatitis B virus with seropharmacological method. BMC Complement Altern Med. 2013;13:239.PubMedCentralCrossRefPubMed Xu H, Wu Q, Peng C, Zhou L. Study on the antiviral activity of San Huang Yi Gan Capsule against hepatitis B virus with seropharmacological method. BMC Complement Altern Med. 2013;13:239.PubMedCentralCrossRefPubMed
17.
go back to reference van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72(11):1747–55.CrossRefPubMed van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72(11):1747–55.CrossRefPubMed
18.
go back to reference Hu X, Lu H, Deng YL, Wan Q, Yie SM. Effect of Rat Medicated Serum Containing Zuo Gui Wan and/or You Gui Wan on the Differentiation of Stem Cells Derived from Human First Trimester Umbilical Cord into Oocyte-Like Cells In Vitro. Evid Based Complement Alternat Med. 2015;2015:825805.PubMedCentralPubMed Hu X, Lu H, Deng YL, Wan Q, Yie SM. Effect of Rat Medicated Serum Containing Zuo Gui Wan and/or You Gui Wan on the Differentiation of Stem Cells Derived from Human First Trimester Umbilical Cord into Oocyte-Like Cells In Vitro. Evid Based Complement Alternat Med. 2015;2015:825805.PubMedCentralPubMed
19.
go back to reference Wang P, Yin B, Shan L, et al. RNA interference-mediated knockdown of astrocyte elevated gene-1 inhibits growth, induces apoptosis, and increases the chemosensitivity to 5-Fluorouracil in renal cancer caki-1 cells. Mol Cells. 2014;37(12):857–64.PubMedCentralCrossRefPubMed Wang P, Yin B, Shan L, et al. RNA interference-mediated knockdown of astrocyte elevated gene-1 inhibits growth, induces apoptosis, and increases the chemosensitivity to 5-Fluorouracil in renal cancer caki-1 cells. Mol Cells. 2014;37(12):857–64.PubMedCentralCrossRefPubMed
20.
go back to reference Han L, Wang Y, Guo X, et al. Downregulation of MDR1 Gene by Cepharanthine Hydrochloride Is Related to the Activation of c-Jun/JNK in K562/ADR Cells. Biomed Res Int. 2014;2014:164391.PubMedCentralPubMed Han L, Wang Y, Guo X, et al. Downregulation of MDR1 Gene by Cepharanthine Hydrochloride Is Related to the Activation of c-Jun/JNK in K562/ADR Cells. Biomed Res Int. 2014;2014:164391.PubMedCentralPubMed
22.
go back to reference Beyer C, Distler O, Distler JH. Innovative antifibrotic therapies in systemic sclerosis. Curr Opin Rheumatol. 2012;24(3):274–80.CrossRefPubMed Beyer C, Distler O, Distler JH. Innovative antifibrotic therapies in systemic sclerosis. Curr Opin Rheumatol. 2012;24(3):274–80.CrossRefPubMed
23.
go back to reference Sun WY, Wang L, Liu H, Li X, Wei W. A standardized extract from Paeonia lactiflora and Astragalus membranaceus attenuates liver fibrosis induced by porcine serum in rats. Int J Mol Med. 2012;29(3):491–8.PubMed Sun WY, Wang L, Liu H, Li X, Wei W. A standardized extract from Paeonia lactiflora and Astragalus membranaceus attenuates liver fibrosis induced by porcine serum in rats. Int J Mol Med. 2012;29(3):491–8.PubMed
24.
go back to reference Bian D, Zhang J, Wu X, et al. Asiatic acid isolated from Centella asiatica inhibits TGF-beta1-induced collagen expression in human keloid fibroblasts via PPAR-gamma activation. Int J Biol Sci. 2013;9(10):1032–42.PubMedCentralCrossRefPubMed Bian D, Zhang J, Wu X, et al. Asiatic acid isolated from Centella asiatica inhibits TGF-beta1-induced collagen expression in human keloid fibroblasts via PPAR-gamma activation. Int J Biol Sci. 2013;9(10):1032–42.PubMedCentralCrossRefPubMed
25.
go back to reference Chan YC, Chang SC, Liu SY, Yang HL, Hseu YC, Liao JW. Beneficial effects of yam on carbon tetrachloride-induced hepatic fibrosis in rats. J Sci Food Agric. 2010;90(1):161–7.CrossRefPubMed Chan YC, Chang SC, Liu SY, Yang HL, Hseu YC, Liao JW. Beneficial effects of yam on carbon tetrachloride-induced hepatic fibrosis in rats. J Sci Food Agric. 2010;90(1):161–7.CrossRefPubMed
26.
go back to reference Cao YL, Li X, Zheng M. Effect of Capparis spinosa on fibroblast proliferation and type I collagen production in progressive systemic sclerosis. Zhongguo Zhong Yao Za Zhi. 2008;33(5):560–3.PubMed Cao YL, Li X, Zheng M. Effect of Capparis spinosa on fibroblast proliferation and type I collagen production in progressive systemic sclerosis. Zhongguo Zhong Yao Za Zhi. 2008;33(5):560–3.PubMed
27.
28.
29.
go back to reference Marsillach J, Ferre N, Camps J, Rull A, Beltran R, Joven J. Changes in the expression of genes related to apoptosis and fibrosis pathways in CCl4-treated rats. Mol Cell Biochem. 2008;308(1-2):101–9.CrossRefPubMed Marsillach J, Ferre N, Camps J, Rull A, Beltran R, Joven J. Changes in the expression of genes related to apoptosis and fibrosis pathways in CCl4-treated rats. Mol Cell Biochem. 2008;308(1-2):101–9.CrossRefPubMed
30.
go back to reference Sisson TH, Maher TM, Ajayi IO, et al. Increased survivin expression contributes to apoptosis-resistance in IPF fibroblasts. Adv Biosci Biotechnol. 2012;3(6A):657–64.PubMedCentralCrossRefPubMed Sisson TH, Maher TM, Ajayi IO, et al. Increased survivin expression contributes to apoptosis-resistance in IPF fibroblasts. Adv Biosci Biotechnol. 2012;3(6A):657–64.PubMedCentralCrossRefPubMed
31.
go back to reference Esfandiari F, Fathi A, Gourabi H, Kiani S, Nemati S, Baharvand H. Glycogen synthase kinase-3 inhibition promotes proliferation and neuronal differentiation of human-induced pluripotent stem cell-derived neural progenitors. Stem Cells Dev. 2012;21(17):3233–43.CrossRefPubMed Esfandiari F, Fathi A, Gourabi H, Kiani S, Nemati S, Baharvand H. Glycogen synthase kinase-3 inhibition promotes proliferation and neuronal differentiation of human-induced pluripotent stem cell-derived neural progenitors. Stem Cells Dev. 2012;21(17):3233–43.CrossRefPubMed
32.
go back to reference Shtutman M, Zhurinsky J, Simcha I, et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A. 1999;96(10):5522–7.PubMedCentralCrossRefPubMed Shtutman M, Zhurinsky J, Simcha I, et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A. 1999;96(10):5522–7.PubMedCentralCrossRefPubMed
Metadata
Title
Wenyang Huazhuo Tongluo formula, a Chinese herbal decoction, improves skin fibrosis by promoting apoptosis and inhibiting proliferation through down-regulation of survivin and cyclin D1 in systemic sclerosis
Authors
Li Han
Hua Bian
Jingfeng Ouyang
Yuefeng Bi
Lei Yang
Songshan Ye
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2016
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-016-1056-6

Other articles of this Issue 1/2016

BMC Complementary Medicine and Therapies 1/2016 Go to the issue